45.76
-0.87 (-1.87%)
| Penutupan Terdahulu | 46.63 |
| Buka | 45.95 |
| Jumlah Dagangan | 411,298 |
| Purata Dagangan (3B) | 795,422 |
| Modal Pasaran | 2,495,096,064 |
| Harga / Pendapatan (P/E Ke hadapan) | 23.42 |
| Harga / Jualan (P/S) | 2.00 |
| Harga / Buku (P/B) | 2.46 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Jul 2025 - 4 Aug 2025 |
| Margin Keuntungan | -17.42% |
| Margin Operasi (TTM) | 15.54% |
| EPS Cair (TTM) | -4.07 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 7.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 242.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 65.54% |
| Nisbah Semasa (MRQ) | 1.58 |
| Aliran Tunai Operasi (OCF TTM) | 197.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 782.12 M |
| Pulangan Atas Aset (ROA TTM) | 4.55% |
| Pulangan Atas Ekuiti (ROE TTM) | -19.70% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | LivaNova PLC | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.88 |
|
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 0.33% |
| % Dimiliki oleh Institusi | 102.63% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Redmile Group, Llc | 31 Mar 2025 | 1,014,139 |
| Exoduspoint Capital Management, Lp | 31 Mar 2025 | 992,447 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 64.00 (Needham, 39.86%) | Beli |
| Median | 60.50 (32.21%) | |
| Rendah | 55.00 (Barclays, 20.19%) | Pegang |
| Purata | 60.00 (31.12%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 44.27 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wolfe Research | 20 May 2025 | 60.00 (31.12%) | Beli | 44.88 |
| Needham | 13 May 2025 | 64.00 (39.86%) | Beli | 44.06 |
| 17 Mar 2025 | 64.00 (39.86%) | Beli | 41.41 | |
| Baird | 08 May 2025 | 61.00 (33.30%) | Beli | 44.07 |
| Barclays | 08 May 2025 | 55.00 (20.19%) | Pegang | 44.07 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |